SciTransfer
Organization

UNIVERZITA KARLOVA

Major Czech research university strong in NLP/machine translation, biomedical research, climate economics, and mathematical sciences across 107 H2020 projects.

University research groupmultidisciplinaryCZ
H2020 projects
107
As coordinator
24
Total EC funding
€40.0M
Unique partners
1285
What they do

Their core work

Charles University is the Czech Republic's flagship research university, with deep strengths in natural language processing and machine translation, biomedical and clinical research, climate economics, and mathematical sciences. Their H2020 portfolio reveals a university that bridges computational linguistics (multilingual health text analysis, quality translation systems) with health research (clinical trials, biomonitoring, cancer prediction) and increasingly climate/energy economics. They contribute both fundamental research and applied expertise — from graph theory and complex systems to real-world diagnostic tools and policy-relevant climate modelling.

Core expertise

What they specialise in

12 projects

Projects spanning Parkinson's disease trials (FAIR-PARK-II), cancer prediction (FORECEE), sepsis diagnostics (SMARTDIAGNOS), dementia technology (INDUCT), and human biomonitoring (HBM4EU).

5 projects

Coordinated GEMCLIME (EUR 1.27M) on climate/energy modelling, plus projects on adaptation, mitigation, consumer behaviour, and energy transition.

Mathematical sciences and complex systemssecondary
6 projects

Projects involving graph limits, dynamic networks, approximation algorithms, and network science — reflected in keywords and MSCA training networks like DISTRO.

Materials science and nanophysicssecondary
4 projects

Coordinated TSuNAMI (EUR 1M) on magnetic nanoarchitectures, plus participation in BEGMAT on layered materials beyond graphene and mass spectrometry (IsoMS).

Evolution & trajectory

How they've shifted over time

Early focus
Biomedical research and NLP
Recent focus
Climate economics and open science

In the early H2020 period (2014-2018), Charles University focused heavily on biomedical research (clinical trials, neuroprotection, omics-based cancer prediction) alongside a strong cluster in computational linguistics and machine translation for healthcare. From 2019 onward, their portfolio shifted markedly toward climate and energy economics, open science policy, and earth system modelling, while maintaining their health research base. The emergence of keywords like "science diplomacy," "FAIR," and "energy transition" signals a strategic move toward research policy and sustainability.

Charles University is pivoting toward climate/energy policy research and open science infrastructure, making them an increasingly valuable partner for Green Deal and EOSC-related consortia.

Collaboration profile

How they like to work

Role: active_partnerReach: Global69 countries collaborated

Primarily an active partner (75 of 107 projects as participant), Charles University joins large international consortia rather than leading them, though they coordinate 24 projects — a healthy ratio for a major university. With 1,285 unique partners across 69 countries, they are a major European hub with exceptionally broad connectivity. Their participation spans everything from small MSCA networks to large-scale infrastructure initiatives like EUROfusion, suggesting adaptability to different consortium structures.

One of the most broadly connected H2020 universities, with 1,285 unique consortium partners spanning 69 countries — covering nearly all EU member states plus significant global reach. This network density makes them an effective bridge between Western European research leaders and Central/Eastern European institutions.

Why partner with them

What sets them apart

Charles University occupies a rare position as a Central European research powerhouse that combines computational linguistics, biomedical science, and climate economics under one roof — a combination almost no other Czech institution can match. Their multilingual NLP expertise applied to healthcare (medical translation, health text mining) is a distinctive niche few universities in Europe fill. For consortium builders, they offer strong research capacity at competitive Central European cost rates, with a proven track record of managing both coordination and participation roles across 107 projects.

Notable projects

Highlights from their portfolio

  • GEMCLIME
    Largest coordinated project (EUR 1.27M) — a MSCA-RISE network building global excellence in climate and energy economics modelling across multiple continents.
  • TSuNAMI
    Coordinated EUR 1M project on magnetic nanoarchitectures combining spin crossover materials with 2D materials — shows deep physics capability beyond their social science profile.
  • HimL
    Applied neural machine translation specifically to healthcare — exemplifies their unique cross-disciplinary strength bridging NLP and medical domains.
Cross-sector capabilities
healthdigitalenvironmentsociety
Analysis note: Profile based on 30 of 107 projects with full details; the remaining 77 are reflected in aggregate statistics. The university's breadth means individual faculty groups may have sharper specializations than this institutional-level profile captures.